BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Arthur Klausner to sit on the "VC Check-Up" panel at the "Life Sciences & Healthcare Venture Summit 2008" in New York City
News | 10. 30. 2008
